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Objectives: Oral submucous fibrosis (OSMF) is a potentially malignant disorder of oral cavity, pharynx and upper 
digestive tract, characterized by progressive inability to open the mouth. Based on clinical and/or histopathological 
features, various classifications and grading systems have been put forth till date. The aim of the present study was 
to study the variance in cheek flexibility in OSMF patients, the observance of which led to the introduction of a 
new grading for the condition.
Material and Methods: The study included 412 patients with OSMF attending to the Department of Oral Medicine 
and Radiology during the period from December 2008 to June 2013. A detailed history and examination of the 
patients was performed with special emphasis on measuring cheek flexibility. Statistical analysis was done using 
Chi-square test and p<0.05 was considered to be statistically significant.
Results: The most common etiological factor was tobacco (73.3%). All the patients reported with burning sensation 
of the mouth and blanching of the mucosa. Malignancy was reported in only 4.6% patients. 60.4% patients showed 
cheek flexibility of 30mm and above, while 29.6% patients showed cheek flexibility between 20-30mm and 10% 
patients showed less than 30mm of cheek flexibility.
Conclusions: The observations of the present study have led to the proposal of a new grading of OSMF based on 
cheek flexibility which could assist in the categorization of the condition by the clinicians.
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Oral submucous fibrosis [OSMF] is a chronic debilitating 
disease of the oral cavity characterized by inflammation 
and progressive fibrosis of the submucosal tissues (1). 
Pindborg and his associates defined the condition as “an 
insidious chronic disease affecting any part of the oral 
cavity and sometimes pharynx. Although occasionally 
preceded by and/or associated with vesicle formation, 
it is always associated with juxtaepithelial inflammatory 
reaction followed by fibroelastic changes in the lamina 
propria, with epithelial atrophy leading to stiffness of the 
oral mucosa causing trismus and difficulty in eating (2).
Susrutha in ancient medicine described a condition si-
milar to OSMF as “vidari”, under the umbrella of mouth 
and throat diseases (3). In 1952, Schwartz (4) described 
a condition of the oral mucosa as “atrophia idiopathi-
ca mucosa oris”, with the term OSMF coined by Joshi 
in 1953 (5). The pathogenesis of the disease is not well 
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tion, limited mouth opening, and difficulty in speech, 
swallowing, hearing, dryness, excess salivation, ulcers, 
vesicles and taste change with their duration were noted. 
Patients were examined for blanching of oral mucosa, 
presence of fibrous bands, ulcers, vesicles, erosions, sta-
tus of the uvula and concurrent presence of other pre-
malignant and malignant conditions. Mouth opening 
and tongue protrusion were measured as previously des-
cribed. Cheek flexibility was measured as the distance, 
in millimeters, from the maxillary incisal midline to the 
cheek retractor during retraction (6). Normal cheek fle-
xibility as observed in males was 35-45 mm and 30-40 
mm in females. Presence of any precancerous condition, 
lesion or any malignancy was confirmed by biopsy. The 
observations were analyzed using the computer pro-
gram, SPSS 12 [SPSS Inc. Chicago, USA]. Statistical 
analysis was done using Chi-square test and p<0.05 was 
considered to be statistically significant.
Results
In the present study, out of 412 OSMF patients, there 
were 220 males and 192 females, with an age range of 
18-56 years. The mean age of the patients was 27.8±8.6 
years. The various predisposing factors in the patients 
were identified and areca nut [73.3%] was the most 
common etiological factor followed by tobacco [69.2%] 
(Table 1). Tobacco was the most common etiological 
factor in males while areca nut was the most common 
etiological factor in females. The various symptoms as 
reported by the patients are shown in table 2. All the pa-
tients complained of burning sensation. 85.1% patients 
Table 1. Distribution of various etiological factors 
known, but the etiology is believed to be multifactorial. 
The condition is particularly associated with areca nut 
chewing, which is the main component of betel quid. 
The habit of betel quid chewing is practiced predomina-
tely in the Indian subcontinent from a long time (1).
Several classifications, staging and grading systems 
based on clinical and histopathological features and 
other aspects of OSMF have been put forth by various 
researchers. The advantages and disadvantages of these 
systems supersede the other leading to confusion. Till 
date no grading system for OSMF has been proposed 
on the basis of flexibility of cheek, so a new system has 
been proposed to for grading the OSMF according to the 
cheek flexibility.
Material and Methods 
This study included 412 patients with OSMF attending 
the Department of Oral Medicine and Radiology, Jodh-
pur Dental College General Hospital, Jodhpur National 
University, Jodhpur, India. Patients who were consu-
ming areca nut and its products and who were clinically 
exhibiting signs and symptoms of OSMF were included 
in this study. Patients with any systemic diseases were 
excluded from the study. The study was conducted from 
December 2008 to June 2013. Ethical clearance was ob-
tained from the institutional ethical committee. A written 
informed consent was obtained from the patients prior to 
the study. A detailed personal history of the patient regar-
ding use of the areca nut and its products, consumption 
of chilly, spicy food, consumption of tobacco and alco-




No. of patients (%)
Females
No. of patients (%)
Total (%)
Areca nut  and its products 131 (43.3) 171 (56.7) 302 (73.3)
Tobacco 150 (52.6) 135 (47.4) 285 (69.2)
Chillies 102 (52) 94 (48) 196 (47.6)
Smoking 147 (71) 60 (29) 207 (50.2)
Alcohol 52 (96.3) 2 (3.7) 54 (13.1)
*No.=Number
Symptoms Males
No. of patients (%)
Females
No. of patients (%)
Total (%)
Burning sensation 220 (53.4) 192 (46.6) 412 (100)
Difficulty in mouth opening 183 (52.1) 168 (47.9) 351 (85.1)
Difficulty in swallowing 91 (50.3) 90 (49.7) 181 (43.9)
Taste change 126 (53.8) 108 (46.2) 234 (56.8)
Dryness of mouth 60 (53.1) 53 (46.9) 113 (27.4)
Excessive salivation 124 (56.1) 97 (43.7) 221 (53.6)
Difficulty in speaking 34 (59.6) 23 (40.4) 57 (13.8)
Vesicles and ulcers 37 (60.7) 24 (39.3) 61 (14.8)
Hearing difficulty 6 (54.5) 5 (45.5) 11 (2.7)
Nasal Twang 27 (57.4) 20 (42.6) 47 (11.4)
*No.=Number
Table 2. Distribution of the various symptoms in OSMF patients.
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reported difficulty in mouth opening, whereas 56.8% 
patients reported change in taste. Dryness of the mouth 
was reported in 27.4% patients while 53.6 patients 
complained of excessive salivation. Vesicles and ulcers 
were reported in 14.8% patients. The signs as observed 
by the examiners are shown in table 3. The most com-
mon sign observed was blanching of the mucosa, which 
was reported in all the patients. Fibrous bands were re-
ported in 94.6% patients. 285 patients showed trismus 
and 100 patients showed restricted tongue movements. 
Deviated uvula was observed in 62 patients. 31.3% pa-
tients showed signs of leukoplakia and 15.3% patients 
had lichen planus. Only 19 patients showed signs of 
malignancy. Males were commonly more affected than 
females and this difference was statistically not signifi-
cant [p>0.05]. The distribution of the patients according 
to cheek flexibility has been shown in table 4. 60.4% 
patients showed cheek flexibility of 30mm and above, 
while 29.6% patients showed cheek flexibility between 
20-30mm and 10% patients showed less than 20mm of 
cheek flexibility.
Discussion
OSMF is a precancerous condition of the oral cavity 
and oropharynx which is predominantly seen in the In-
dian subcontinent and Southeast Asian countries and is 
now globally considered an Indian disease. The overall 
prevalence rate in India is believed to be about 0.2% to 
0.5% and prevalence by gender varying from 0.2-2.3% 
in males and 1.2-4.57% in females (7,8). It is considered 
to have a high degree of malignant potential, which ran-
ges between 2.3% and 7.6% (9). The pathophysiology of 
OSMF is complex, and various factors such as, ingestion 
of chilies, genetic susceptibility, nutritional deficiencies, 
altered salivary constituents, autoimmunity and collagen 
disorders may be involved in the pathogenesis (7). Are-
ca nut and its products [73.3%] was the most common 
etiological factor in the present study. The condition is 
preceded by burning sensation of the oral mucosa, ul-
ceration and pain. OSMF is characterized by blanching 
of oral mucosa, reduced movement and depapillation of 
tongue, depigmentation of oral mucosa, and progressive 
reduction of mouth opening (10,11). Nasal twang due to 
fibrosis of nasopharynx and hearing impairment due to 
stenosis of eustachian tube may be observed in advanced 
stages of the condition. Majority of OSMF patients pre-
sent with irreversible moderate-to-severe condition. The 
changes of OSMF are limited to oral tissues and similar 
to those of scleroderma. It may be associated with oral 
leukoplakia and other potentially malignant disorders or 
with malignancy such as squamous cell carcinoma (10). 
The higher prevalence of leukoplakia [31.3%] in OSMF 
leading to oral carcinoma was observed similar to the 
finding of Thukanaykanpalayam et al. (8). The pre-
cancerous nature of OSMF has been proved by, higher 
occurrence of OSMF in oral squamous cell carcinoma 
patients, histological diagnosis of cancer without any 
clinical suspicion in OSMF, high frequency of epithelial 
dysplasia and higher prevalence of leukoplakia among 
OSMF. The debate over the initiation of malignancy in 
OSMF due to epithelium or due to connective tissue is 
still unanswered (8,12). However, it has been suggested 
Signs Males
No. of patients (%)
Females
No. of patients (%)
Total
Blanching of oral mucosa 220 (53.4) 192 (46.6) 412 (100)
Presence of fibrous bands 212 (54.3) 178 (45.7) 390 (94.6)
Trismus 146 (51.2) 139 (48.8) 285 (69.2)
Restriction of tongue
movements
53 (53) 47 (47) 100 (24.3)
Erythematous areas/ ul-
cers/ erosions/ vesicles
37 (60.6) 24 (39.4) 61 (14.8)
Depapillation of tongue 116 (54.7) 96 (45.3) 212 (51.5)
Deviated/ bud like uvula 33 (53.2) 29 (46.8) 62 (15)
Atrophic tonsils 10 (62.5) 6 (37.5) 16 (3.9)
Leukoplakia 69 (53.4) 60 (46.6) 129 (31.3)
Lichenplanus 36 (57.1) 27 (42.9) 63 (15.3)
Malignancy 11 (57.9) 8 (42.1) 19 (4.6)
*No.=Number
Table 3. Distribution of the various signs in OSMF patients.
Cheek flexibility Males
No. of patients (%)
Females
No. of patients (%)
Total (%)
30mm and above 137 (55) 112 (45) 249 (60.4)
Between 20-30mm 67 (54.9) 55 (45.1) 122 (29.6)
Less than 20mm 24 (58.5) 17 (41.5) 41 (10)
*No.=Number
Table 4. Distribution of patients according to cheek flexibility.
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that the pathology develops within the epithelium due 
to intraoral trauma and various factors such as, irritation 
from jagged teeth, sharp overhanging restoration, ill-fit-
ting dentures, jacket crowns, prolong use of tobacco and 
poor oral hygiene (8,13). Only 19 patients showed signs 
of malignancy in the present study.
Treatment modalities for relieving the symptoms have 
been advocated, but have not been successful so far. 
The first step of preventive measure should be in dis-
continuation of habit, which can be encouraged through 
education, counseling and advocacy. Medical treatment 
is symptomatic and predominantly aimed at improving 
mouth movements. But each treatment has its own limi-
tations (14).
Based on the features of OSMF, such as clinical symp-
toms, maximal mouth opening, and palpable fibrous 
bands, many researchers have divided it into different 
clinical stages. Pindborg JJ (15) reviewed the first clini-
cal classification of OSMF based on the physical findings 
of the disease. But this classification did not include the 
mouth opening of the patients. Ahuja and Agrawal (16) 
classified submucous fibrosis clinically based on the ex-
tent and type of fibrosis.
Lai DR et al. (17) in 1995 classified OSMF on the ba-
sis of mouth opening but clinical symptoms of patients 
were not considered in this classification. Khanna and 
Andrade (18) categorized OSF into different stages con-
sidering the clinical features, histological features and 
mouth opening of the patients. Chandramani More et al. 
(10) in 2011 provided a clinical staging of OSMF con-
sidering the symptoms of the disease and presence of 
the palpable fibrous bands. None of the above mentio-
ned researchers considered check flexibility in grading 
or staging of OSMF. Hence, through the results of the 
present study, OSMF can be graded as follows based on 
cheek flexibility:
• Grade 1 [Early]: Cheek flexibility of 30 mm and above
• Grade 2 [Mild]: Cheek flexibility between 20-30 mm
• Grade 3 [Moderate]: Cheek flexibility less than 20 mm
• Grade 4 [Severe]: Any of the above condition without 
concurrent presence of potential malignant lesions
• Grade 5 [Advanced]: Any of the above condition with 
concurrent presence of oral carcinoma
An attempt has been made to propose a new grading sys-
tem for OSMF, to assist the practitioners and researchers 
in the categorization of this premalignant condition and 
to aid in early detection thereby leading to timely ma-
nagement.
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